JANICE REYNOLDS: Open Payments
NPI 1720112519 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$443 in 20 payments from 11 companies in 2025. Trend: 2023 $324 · 2024 $383 · 2025 $443
Food & beverage: $443
| Company | Payments | Amount |
|---|---|---|
| Exeltis, USA Inc. | 2 | $73 |
| Hologic Sales and Service, LLC | 3 | $72 |
| Astellas Pharma US Inc | 3 | $64 |
| Biogen, Inc. | 2 | $57 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| Organon LLC | 2 | $30 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $25 |
| Solventum Corporation | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Becton, Dickinson and Company | 1 | $21 |
Products named: SLYND, Veozah, ZURZUVAE, NEXPLANON, NOVASURE, Mirena, Sonata Sonography-Guided Transcervical Fibroid Ablation System, APTIMA.
Industry payments across TX — which companies pay providers there.
